Is chondroblastoma fatal?
Is chondroblastoma fatal?
It is mostly localised at the level of the epiphysis of long bones. We report a fatal case of pure metaphyseal CB of the tibia in a 9-year-old boy whose pulmonary metastases developed soon after operative therapy of the primary tumour.
Is chondroblastoma a cancer?
Chondroblastoma is a rare type of noncancerous bone tumor that starts from cartilage. It most often affects the ends of the long bones, near the growth plate, in the arms at the shoulder, and in the legs at the hip and knee. It is more common in children and young adults and affects males more than females.
Is chondroblastoma painful?
Pain is the most common symptom of a chondroblastoma. Because the tumors are typically found near joints, it is joint pain that will often prompt a visit to the doctor.
Is chondroblastoma genetic?
By in-depth genetic analyses of a chondroblastoma-like osteosarcoma, we detect a genetic profile that is distinct from those previously reported in benign and malignant bone tumors.
Is chondroblastoma life threatening?
Although usually benign, chondroblastoma metastasizes on rare occasions, with fatal results.
What does Chondroma mean?
(kon-DROH-muh) A rare, slow-growing tumor that is made up of cartilage and forms on or in bones or soft tissue. It is not cancer. The tumor usually occurs in the hands or feet, but it may also occur in the upper arm, thigh, collarbone, ribs, pelvis, spine, skull, and nasal sinuses.
Can a chondroblastoma metastasis?
Although a chondroblastoma is considered a benign tumor, it has the potential to spread (metastasize) to the lungs. Metastasis is rare, occurring in less than 1 percent of cases.
How is chondroblastoma diagnosed?
How is chondroblastoma diagnosed? In addition to a complete medical history and physical examination, diagnostic procedures for chondroblastoma may include X-rays and magnetic resonance imaging (MRI).
Is Chondroblastoma life threatening?
Are there H3F3A mutations in giant cell tumours?
H3F3A p.Gly34Trp (p.G34W) alterations were found in all but one case of GCT which harboured a p.G34L mutation. We additionally identified distinct H3.3 mutations in 2/103 osteosarcomas (one p.G34R in H3F3A, and one p.G34R mutation in H3F3B) and in 1/75 chondosarcomas ( H3F3A p.K36M) 2.
Are there any H3F3A mutations in chondosarcomas?
We additionally identified distinct H3.3 mutations in 2/103 osteosarcomas (one p.G34R in H3F3A, and one p.G34R mutation in H3F3B) and in 1/75 chondosarcomas ( H3F3A p.K36M) 2. Since then, others have reported a H3F3A mutation in another osteosarcoma (1/10, p.G34W) 3 .
Where do H3.3 mutations occur in GCT?
In addition, we explored the driver landscape of GCT through whole genome, exome and targeted sequencing (14 gene panel). We found that H3.3 mutations, namely mutations of glycine 34 in H3F3A, occur in 96% of GCT.